MiMedx Group (MDXG) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to MiMedx Group (MDXG) Tops Q3 EPS by 1c

MiMedx Announces Record Results for Third Quarter of 2015

October 29, 2015 7:30 AM EDT

MARIETTA, Ga., Oct. 29, 2015 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, announced today its record results for the third quarter of 2015.

Third Quarter 2015 Highlights are:

Q3 is 16th consecutive quarter of meeting or exceeding revenue guidance YTD 2015 revenue of $135.5 million increased by 72% over same... More